Literature DB >> 15755680

Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice.

Patrick Dion1, Vijayalakshmi Shanmugam, Claudia Gaspar, Christiane Messaed, Inge Meijer, André Toulouse, Janet Laganiere, Julie Roussel, Daniel Rochefort, Simon Laganiere, Carol Allen, George Karpati, Jean-Pierre Bouchard, Bernard Brais, Guy A Rouleau.   

Abstract

Oculopharyngeal muscular dystrophy (OPMD) is a late-onset disorder caused by a (GCG)n trinucleotide repeat expansion in the poly(A) binding protein nuclear-1 (PABPN1) gene, which in turn leads to an expanded polyalanine tract in the protein. We generated transgenic mice expressing either the wild type or the expanded form of human PABPN1, and transgenic animals with the expanded form showed clear signs of abnormal limb clasping, muscle weakness, coordination deficits, and peripheral nerves alterations. Analysis of mitotic and postmitotic tissues in those transgenic animals revealed ubiquitinated PABPN1-positive intranuclear inclusions (INIs) in neuronal cells. This latter observation led us to test and confirm the presence of similar INIs in postmortem brain sections from an OPMD patient. Our results indicate that expanded PABPN1, presumably via the toxic effects of its polyalanine tract, can lead to inclusion formation and neurodegeneration in both the mouse and the human.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15755680     DOI: 10.1016/j.nbd.2004.09.021

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  16 in total

1.  Executive functions are impaired in heterozygote patients with oculopharyngeal muscular dystrophy.

Authors:  Raffaele Dubbioso; Pasquale Moretta; Fiore Manganelli; Chiara Fiorillo; Rosa Iodice; Luigi Trojano; Lucio Santoro
Journal:  J Neurol       Date:  2011-09-29       Impact factor: 4.849

2.  Proteomic analysis reveals that wildtype and alanine-expanded nuclear poly(A)-binding protein exhibit differential interactions in skeletal muscle.

Authors:  Ayan Banerjee; Brittany L Phillips; Quidong Deng; Nicholas T Seyfried; Grace K Pavlath; Katherine E Vest; Anita H Corbett
Journal:  J Biol Chem       Date:  2019-03-05       Impact factor: 5.157

3.  A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1.

Authors:  Aymeric Chartier; Béatrice Benoit; Martine Simonelig
Journal:  EMBO J       Date:  2006-04-27       Impact factor: 11.598

4.  Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy.

Authors:  Ami Mankodi; Thurman M Wheeler; Reena Shetty; Kelly M Salceies; Mark W Becher; Charles A Thornton
Journal:  Neurobiol Dis       Date:  2011-09-21       Impact factor: 5.996

Review 5.  The potential role of ribosomal frameshifting in generating aberrant proteins implicated in neurodegenerative diseases.

Authors:  Norma M Wills; John F Atkins
Journal:  RNA       Date:  2006-05-18       Impact factor: 4.942

6.  Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology.

Authors:  Katherine E Vest; Brittany L Phillips; Ayan Banerjee; Luciano H Apponi; Eric B Dammer; Weiting Xu; Dinghai Zheng; Julia Yu; Bin Tian; Grace K Pavlath; Anita H Corbett
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

7.  Interactions between homopolymeric amino acids (HPAAs).

Authors:  Yoko Oma; Yoshihiro Kino; Kazuya Toriumi; Noboru Sasagawa; Shoichi Ishiura
Journal:  Protein Sci       Date:  2007-08-31       Impact factor: 6.725

Review 8.  Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.

Authors:  Vittoria Pagliarini; Piergiorgio La Rosa; Claudio Sette
Journal:  Hum Genet       Date:  2017-04-22       Impact factor: 4.132

Review 9.  PABPN1: molecular function and muscle disease.

Authors:  Ayan Banerjee; Luciano H Apponi; Grace K Pavlath; Anita H Corbett
Journal:  FEBS J       Date:  2013-05-24       Impact factor: 5.542

10.  The Inhibition of Heat Shock Protein 90 Facilitates the Degradation of Poly-Alanine Expanded Poly (A) Binding Protein Nuclear 1 via the Carboxyl Terminus of Heat Shock Protein 70-Interacting Protein.

Authors:  Chao Shi; Xuan Huang; Bin Zhang; Dan Zhu; Huqiao Luo; Quqin Lu; Wen-Cheng Xiong; Lin Mei; Shiwen Luo
Journal:  PLoS One       Date:  2015-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.